Silymarin
Indications
Registered South African indications:
- Aid in the treatment of alcohol-induced liver disease
Cautions
Contraindications
- Hypersensitivity to the active ingredient or any of its excipients
- Pregnancy
- Breastfeeding
Cautions
- Renal impairment
- Hepatic impairment
- Elderly
- Porphyria
- History of Stevens-Johnson Syndrome
- History of drug-induced phototoxicity
Adult dosage
Forms avail. in SA and covered in this monograph: tab, cap
Alcohol-induced liver disease
- Oral (tab): Initial: 140mg, 8hrly; Maintenance: 70mg, 8hrly
- Oral (cap): 140mg, 8hrly; Max: 420mg/24 hrs
Silymarin is not suitable for treating cases of acute poisoning
The duration of treatment to be decided by the prescribing doctor
The capsules are to be swallowed whole and unchewed with an appropriate amount of liquid
Paediatric dosage
Not indicated for use in children below 12 years
Special populations
Pregnancy
- Contraindicated
- There are no adequate data from the use of silymarin in pregnant women. Therefore, in these circumstances silymarin should not be administered
Breastfeeding
- Contraindicated
- There are no adequate data from the use of silymarin in breastfeeding women. Therefore, in these circumstances silymarin should not be administered
Renal Impairment
Hepatic Impairment
Elderly
Porphyria Information
Drugs in Sport
- Permitted - No warnings
Adverse reactions
Respiratory Disorders
- Dyspnoea
Gastrointestinal Disorders
- Diarrhoea
Skin and Subcutaneous Tissue Disorders
- Rash
- Urticaria
Immune, Blood and Lymphatic System Disorders
- Hypersensitivity reactions
Interactions
Due to the herbal nature of this product, limited data related to drug interactions are available
- UGT1A1 inhibitor
- UGT1A1 substrates
- UGT1A1 inducers
- Lipid-lowering agents
- HMG CoA reductase inhibitors
- Nonsteroidal anti-inflammatory drug
- Antiepileptic agents
- Immunosuppressants
- Mycophenolate mofetil
- Oestrogens
- Estradiol
- Dolutegravir
- Zidovudine
- Rifampicin
- Probenecid
- Irinotecan
- Furosemide
- Losartan
- Raloxifene
- Levothyroxine
Monitoring
None routine
Prescribing points
- The treatment with silymarin does not serve as a substitute for the abstention from the cause of liver damage (e.g. alcohol)
- If icterus (light to dark yellow tinge of the skin, yellow discolouration of the white of the eye) occurs, the doctor is to be consulted
Mechanism of action
Silymarin (also known as silybin or silibinin) is standardised herbal extract of milk thistle seeds. Silymarin has a membrane-stabilising effect and an RNA-synthesis stimulating effect on hepatocytes.
Silymarin has free radical capturing powers, silymarin possesses antiperoxidative activity. The pathophysiological process of lipid peroxidation which is responsible for the destruction of cell membranes is interrupted or reduced. Furthermore, in liver cells, which have already sustained damage, silymarin stimulates protein synthesis and normalises phospholipid metabolism.
The enhancement of protein synthesis by silymarin is due to its stimulation of RNA polymerase I, an enzyme which is located in the nucleus. This leads to increased formation of ribosomal RNA and structure and function proteins (enzymes) are therefore synthesised in greater amounts.
Dosage forms
- Capsule
- Tablet
Formulation
Tablet 70mg
- Legalon (Xixia Pharmaceuticals) originator
Capsule 140mg
- Legalon Forte (Xixia Pharmaceuticals) originator
References
1. SAMF_12th Edition_Page 55 2. PI: Legalon 70, Takeda (Pty) Ltd. Date of publication of PI: Oct 1990. Updated 12 May 2020 [https://drive.google.com/drive/folders/10-3Cs6y9R6u_aQpHFbsvEA38zwIpUPgt] 3. Medicine Price Registry - 11 March 2020. Updated 12 May 2020 [https://docs.google.com/spreadsheets/d/18hXNriN78NcpWFDi-HglXSg5lOu_OX4e/edit#gid=1214068546] 4. PI: Legalon® Forte capsules, Takeda (Pty) Ltd. Date of publication of PI: 2 Oct 2014. Updated 12 May 2020 [https://drive.google.com/drive/folders/1roBB4DVhalP9NgrAYUth2aMzzlKLsTg4] 5. Clinical Pharmacologist - Dr. M Irhuma. Feedback regarding dosing queries [https://trello.com/c/JtweUfth/346-urgent-silymarin-legalon-legalon-forte-update-and-query-for-medicine-interactions 6. Voinovich D, et al. (2009). Journal of Pharmaceutical Sciences. 98 (11): 4119–29 7. Schull PD. NURSE’S DRUG Handbook (©McGraw-Hill) - Seventh edition. McGraw-Hill Education, LLC 8. The DrugBank database (version 5.1.6, released 2020-04-22) 9. NAPOS : Porphyria information: silymarin. Updated 13 May 2020 [http://www.drugs-porphyria.org/languages/UnitedKingdom/s3.php?l=gbr&atc_code=A05BA03] 10. SAID: Drugs in sport status: silymarin. Updated 13 May 2020 [http://www.drugfreesport.org.za/online-medication-check/legalon] **No SPC available
Brands & products
4 products · stale NAPPI snapshot · refreshed 5/29/2026 · 158 days oldtabletGeneric· 2 products
from R3.07/unit| Product | Strength | Pack | Sched | SEP | Unit | Disp fee | NAPPI |
|---|---|---|---|---|---|---|---|
| Legalon 70 | 70 mg | 100 | S0 | R306.55 | R3.07 | R109.54 | 785849017 |
| Legalon 70 | 70 mg | 40 | S0 | R151.53 | R3.79 | R64.31 | 785849009 |
capsuleGeneric· 2 products
from R6.03/unit| Product | Strength | Pack | Sched | SEP | Unit | Disp fee | NAPPI |
|---|---|---|---|---|---|---|---|
| Legalon ® Forte | 140 mg | 100 | S0 | R603.02 | R6.03 | R173.18 | 3000442001 |
| Legalon ® Forte | 140 mg | 30 | S0 | R212.65 | R7.09 | R83.71 | 3000442002 |
- Legalon
- Legalon Forte
Medical aid coverage
data not yet integrated- Comprehensive Series—
- Executive Plan—
- KeyCare Series—
- Priority Series—
- Saver Series—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- BonClassic—
- BonComprehensive—
- BonEssential—
- BonFit Select—
- BonSave—
- BonStart—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Beryl—
- Emerald—
- Onyx—
- Ruby—
- Sapphire—
- Tanzanite One—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Aquarium Option—
- Efficiency Option—
- Marine Option—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.